A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system

[1] Adeyinka A(1999)Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19 Cancer Genet Cytogenet 111 144-148

[2] Mertens F(1999)Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization Cancer Genet Cytogenet 110 94-102

[3] Idvall I(1996)Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis Cancer Genet Cytogenet 86 18-21

[4] Bondeson L(2004)Comparative multi-methodological measurement of ERBB2 status in breast cancer J Pathol 202 286-298

[5] Pandis N(2005)Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines Hum Pathol 36 250-261

[6] Aubele M(2000)HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma Am J Clin Pathol 113 852-859

[7] Mattis A(1999)Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples Cancer 87 312-318

[8] Zitzelsberger H(2001)Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization J Clin Oncol 19 354-363

[9] Walch A(2000)Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization Pathol Res Pract 196 227-233

[10] Kremer M(1999)Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization Lab Invest 79 387-393

[1] Adeyinka A(1999)Multiple polysomies in breast carcinomas: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19 Cancer Genet Cytogenet 111 144-148

[2] Mertens F(1999)Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization Cancer Genet Cytogenet 110 94-102

[3] Idvall I(1996)Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis Cancer Genet Cytogenet 86 18-21

[4] Bondeson L(2004)Comparative multi-methodological measurement of ERBB2 status in breast cancer J Pathol 202 286-298

[5] Pandis N(2005)Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines Hum Pathol 36 250-261

[6] Aubele M(2000)HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma Am J Clin Pathol 113 852-859

[7] Mattis A(1999)Detection and quantitation by fluorescence in situ hybridization (FISH) and image analysis of HER-2/neu gene amplification in breast cancer fine-needle samples Cancer 87 312-318

[8] Zitzelsberger H(2001)Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization J Clin Oncol 19 354-363

[9] Walch A(2000)Evaluation of numerical abnormalities of chromosomes 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization Pathol Res Pract 196 227-233

[10] Kremer M(1999)Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization Lab Invest 79 387-393